adaspor ers
international medical service - coldsterilizing solution, based on adazone and peracetic acid, to be used in ers, endoscopes sterilizer. - activated and diluted solution adazone (5,7-diphenyl-1,3 diazoadamantan-6-one) 0.00055 g., peracetic acid 0,0900 g., excipients and purified water q.s. to 100 ml. - adazone and peracetic acid - connect one bottle of solution a and one bottle of solution b to the automated single shot sterilizer endoscope reprocessors ers (manufactured by cisa) according to the operator's manual.
hydrocortisone and acetic acid solution
akorn operating company llc - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - acetic acid 20.75 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation. hypersensitivity to hydrocortisone and acetic acid or any of the ingredients; herpes simplex, vaccinia and varicella. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.
acetic acid solution/ drops
bausch & lomb incorporated - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 2 mg in 1 ml
acetic acid solution
nucare pharmaceuticals,inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.
acetic acid solution
preferred pharmaceuticals inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.
acetic acid solution
trupharma, llc - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.
acetic acid solution
nucare pharmaceuticals,inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.
antec international antec farm fluid disinfectant
janos hoey pty ltd - acetic acid | creosote, coal tar - fungicide - feed shed | hatchery | piggery | poultry shed | shearing shed or instruments | shearing shed floors - bacterial prevention, cleansing or disin | disinfecting
apo-tranexamic acid tranexamic acid 500 mg tablet blister pack
southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; purified talc; colloidal anhydrous silica; povidone; vanillin; macrogol 8000; magnesium stearate; titanium dioxide; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.
apo-tranexamic acid tranexamic acid 500 mg tablet bottle
southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; purified talc; croscarmellose sodium; vanillin; povidone; macrogol 8000; titanium dioxide; magnesium stearate; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.